openPR Logo
Press release

U.S. Scar Treatment Market Size and its Growth Prospect in the Near Future

08-09-2018 06:01 AM CET | Health & Medicine

Press release from: P&S Intelligence - Healthcare

U.S. Scar Treatment Market Size and its Growth Prospect in

The U.S. scar treatment market size is expected to reach $11.3 billion by 2023. The market is mainly driven by increasing number of surgeries for the improvement of physical appearance, growing prevalence of skin problems leading to scar formation, increasing expenditure on personal care, and technological advancements in dermatological products.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/us-scar-treatment-market/report-sample

The scar treatment market is categorized into post-surgical scar, acne scar, keloid and hypertrophic scar, contracture scar, and stretch mark, on the basis of type of scar. In 2017, post-surgical scar category accounted for the largest share of, 32.5%, in the U.S. market. This is attributed to the increasing number of surgeries performed for the treatment of various diseases in the country.

The key players operating in the U.S. scar treatment industry are launching various topical products that are intended to be used at-home by the users. For instance, in April 2018, Sonoma Pharmaceuticals Inc. received approval from the United States Food and Drugs Administration (USFDA) for an antimicrobial post-therapy gel. It used to manage post-non-ablative laser therapy procedures and post-microdermabrasion therapy as well for superficial chemical peels. The product can also be used to relieve itch and pain from minor skin related problems.

Browse report at: https://www.psmarketresearch.com/market-analysis/us-scar-treatment-market

Some of the other key players operating in the U.S. scar treatment market are Revitol Corporation Inc., CCA Industries Inc., Scarguard Labs LLC, Quantum Health, Valeant Pharmaceuticals International Inc., Pacific World Corporation, Merz Pharma GmbH & Co. KGaA, and Johnson & Johnson.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Scar Treatment Market Size and its Growth Prospect in the Near Future here

News-ID: 1170405 • Views:

More Releases from P&S Intelligence - Healthcare

Cleanroom Technology Market Report 2023 by Key Players Analysis - Kimberly-Clark, Azbil Corporation, Ardmac, Alpiq, Illinois Tool Works Inc
Cleanroom Technology Market Report 2023 by Key Players Analysis - Kimberly-Clark …
According to a recent research report by P&S Intelligence, the global cleanroom technology size is projected to reach $5.0 billion by 2023. Various factors leading to the growth of the global cleanroom technology market include increasing demand for certified products, technological advancements in cleanrooms, growing prevalence of infectious diseases etc. **Download report sample at: http://bit.ly/2x2XXka With the increased number of biological products coming to the market, new practices to provide high assurance
Increasing Prevalence of Skin Problems is Driving the Growth of the Middle Eastern Market
Increasing Prevalence of Skin Problems is Driving the Growth of the Middle Easte …
According to P&S Intelligence, Middle East dermal fillers market is projected to cross $67.7 million by 2023, growing at a CAGR of 11.9% between 2018-2023. The growth is mainly led by increasing prevalence of skin problems, growing aging population, increasing awareness about age related skin problems, thriving medical tourism industry, and increase in disposable income. Explore report sample at: https://www.psmarketresearch.com/market-analysis/middle-east-dermal-fillers-market/report-sample Injectable lip enhancement is a procedure of strategically injecting dermal fillers into
Age-Related Macular Degeneration Therapeutics - Pipeline Analysis, Clinical Trials and Developments
Age-Related Macular Degeneration Therapeutics - Pipeline Analysis, Clinical Tria …
As per the findings of the research, most of the drug candidates of Age-related macular degeneration pipeline are being developed to be administered by intra-vitreal route. Explore report sample at: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-therapeutics-pipeline-analysis/report-sample Many technologies are being developed that can bring the innovative treatment which can control the progression of Age-related macular degeneration. Some of these technologies include but are not limited to, HINGESCREEN technology platform, and CrossMab technology platform. There are different novel molecule
Molecular Biology Kits and Reagents and Enzymes Market Trends, Share, Growth Drivers and Forecast to 2022
Molecular Biology Kits and Reagents and Enzymes Market Trends, Share, Growth Dri …
The molecular biology kits and reagents and enzymes market is growing due to increasing geriatric population, increasing prevalence of infectious diseases, and growing cases with genetic disorders. In addition, increasing healthcare expenditure resulting in improvement in research activities is further driving the market growth. Explore report sample at: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market/report-sample Based on product, kits and reagents accounted for the largest market in the global market in 2015, and it is expected to witness

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the